Hengyu Biotech follows the GLP system to provide biosafety testing services with assurance at the phases of drug R&D and commercial production. Hengyu biotech services currently cover studies on viral clearance and inactivation studies, inactivation studies, Cell line characterization and Validation，and raw material testing. Hengyu biotech biosafety testing team consists of more than 90 professionals from industry-leading cell and virus preparation companies and biologics R&D institutions as well as first-class universities in China. Hengyu biotech has accumulated more than 10 years of experience in biosafety testing technology, and have completed more than 100 projects successfully.
Viral Clearance and Inactivation Studies
Biosafety Testing
Viral Clearance and Inactivation Studies
Laboratorial platforms
- P2 laboratory of about 500m2
- HyPure virus series (high-titer and high-purity)
- Whole-process monitoring from sample receipt to results
- GLP-compliant record tracking
- Supported by GE AKTA pure system, KROSFLO® TFF system, and Sepure SCG100-V2 system
Service coverage
- Low-pH incubation
- Organic solvent/surfactant treatment (S/D method)
- Pasteurization
- Dry heat inactivation
- Chromatography
- Membrane filtration
Available indicator viruses
- Comprehensive coverage of commonly used indicator viruses (MVM, x-MuLV, REO-3, Sindbis Virus, VSV, and PRV) in pharmacopoeia examples.
- TCID50 assay and qPCR quantitative assay